Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slac2-b Activators

Slac2-b activators are a specialized group of chemicals that specifically target and modulate the function of the protein Slac2-b, which is known to be involved in intracellular signaling pathways. Slac2-b, also referred to as EXPH5 or exophilin-5, is a member of the Slac2 family of proteins, which are characterized by their role in the regulation of vesicle trafficking. The activators of Slac2-b typically bind to the protein at specific sites, leading to a conformational change that can increase the protein's activity. This activation process is crucial for the proper functioning of the protein in its cellular context. The chemical structure of these activators can vary widely, but they share the common feature of being able to interact with Slac2-b in a way that promotes its activation state.

These molecules exert their influence by facilitating the interaction of Slac2-b with other proteins or lipids within the cell, thereby impacting the dynamics of vesicle transport. The precise mechanisms by which Slac2-b activators exert their effects can depend on the structure of the activator molecule and the specific domain of the Slac2-b protein that is targeted. While some activators might mimic the effect of physiological ligands or protein partners, others might stabilize Slac2-b in an active conformation or enhance its association with membranes or cytoskeletal elements. The diversity of these activators reflects the complex regulatory environment of intracellular transport and signaling, wherein Slac2-b plays a pivotal role.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin elevates cAMP levels by activating adenylyl cyclase. Elevated cAMP can influence exocytotic machinery, potentially increasing Slac2-b activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates PKC, a kinase involved in various cellular processes, including vesicle transport. PKC activation may enhance Slac2-b activity in vesicle transport.

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$94.00
$259.00
2
(2)

Ionomycin raises intracellular calcium levels. Elevated calcium can promote exocytosis and may influence Slac2-b-mediated vesicle transport.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$97.00
$224.00
30
(1)

8-Br-cAMP, a cAMP analog, can influence vesicle transport machinery, which may modulate Slac2-b's role in the process.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

By chelating calcium, BAPTA-AM modulates calcium-mediated signaling. Altering calcium signaling can influence vesicle transport and Slac2-b's role therein.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein, by inhibiting tyrosine kinases, can affect vesicle docking and fusion events, possibly modulating Slac2-b activity.

KN-93

139298-40-1sc-202199
1 mg
$178.00
25
(1)

KN-93, an inhibitor of CaMKII, affects calcium-dependent processes like vesicle exocytosis, potentially influencing Slac2-b's role.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 elevates intracellular calcium levels, which can affect vesicle exocytosis and Slac2-b's role in the process.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

ML-7 inhibits myosin light chain kinase (MLCK), affecting actin-myosin interactions. Changes here can potentially affect Slac2-b-mediated transport processes.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$260.00
$799.00
36
(2)

Latrunculin A disrupts actin filaments. Changes in the actin cytoskeleton can influence vesicle transport and Slac2-b's role in this process.